See also this year's filing and all EDGAR filings for this company.
PDF Report 0001589150_2024_Regen_Biopharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Liabilities', 'value': 5378455, 'size_variable': 'Assets', 'size_value': 161084, 'ratio': 33.4, 'threshold': 20} |
Graph
Absolute values for 0001589150, Regen Biopharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 131,037 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 222,580 |
| 4 | LiabilitiesCurrent | 5,308,003 |
| 5 | LiabilitiesNoncurrent | 149,614 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 45,926 |
| 9 | ResearchAndDevelopmentExpense | 209,721 |
| 10 | remainder_Expenses | 654,988 |
| 11 | remainder_Revenues | 126,412 |
| 12 | remainder_NetIncome | 2,198,985 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 353,617 |
| 1 | Liabilities | 5,457,617 |
| 2 | Expenses | 910,635 |
| 3 | Revenues | 126,412 |
| 4 | StockholdersEquity | -5,104,000 |
| 5 | NetIncome | 1,414,762 |
| 6 | ComprehensiveNetIncome | 1,414,762 |
| 7 | BaseVar | 4,523,633 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.34 |
| 9 | EconomicCapitalRatio | 0.577 |
Edgar->Model Mapping
Feature Distribution
Change over Time
